SODIUM PHENYLACETATE AND SODIUM BENZOATE (MAIA PHARMACEUTICALS, INC)
Welcome to the PulseAid listing for the SODIUM PHENYLACETATE AND SODIUM BENZOATE drug offered from MAIA PHARMACEUTICALS, INC. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | MAIA PHARMACEUTICALS, INC |
| NON-PROPRIETARY NAME: | sodium phenylacetate and sodium benzoate |
| SUBSTANCE NAME: | SODIUM PHENYLACETATE; SODIUM BENZOATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-22 |
| END MARKETING DATE: | 0000-00-00 |
SODIUM PHENYLACETATE AND SODIUM BENZOATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | SODIUM PHENYLACETATE AND SODIUM BENZOATE from MAIA PHARMACEUTICALS, INC |
| LABELER NAME: | MAIA PHARMACEUTICALS, INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100; 100(mg/mL; mg/mL) |
| START MARKETING DATE: | 2017-05-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70511-101_35351089-b792-4444-942f-9ab0852831ea |
| PRODUCT NDC: | 70511-101 |
| APPLICATION NUMBER: | ANDA208521 |
Other SODIUM PHENYLACETATE; SODIUM BENZOATE Pharmaceutical Manufacturers / Labelers:
